Given the importance of HGF/Met signaling in these cell lines, and the fact that foretinib is a kinase inhibitor designed to target HGF/Met signaling, the powerful anti-cancer effects of foretinib on EC cells that were observed in the current study are not surprising. This evidence concerns the gene HGF and cancer.